echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Medicine plate's adverse trend leads the rise of safe harbor effect to further highlight

    Medicine plate's adverse trend leads the rise of safe harbor effect to further highlight

    • Last Update: 2014-07-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Last week, the CSI 300 index fell 1.54%, led by the pharmaceutical sector Data shows that as of September 28, the China Securities pharmaceutical index rose by more than 5% last week, ranking first in the top 10 China securities industry indexes At present, the net value of huitianfu, the only ETF with CSI medical index as the tracking target, has also increased rapidly In just two weeks of listing, the net value of the fund has climbed to 1.0653 yuan, and the net value of last week has increased by as much as 5.36% The outstanding profit-making effect has also made the fund warmly sought after by the fund, with a weekly turnover rate of 42.26%, significantly higher than that of last week's ETF The average turnover rate is 14.60%, ranking in the top five of all ETFs As a classic defense variety of "advancing and retreating", the "safe harbor effect" of pharmaceutical stocks is further highlighted The enthusiasm of the pharmaceutical sector for long-term growth has also made huitianfu Zhongzheng medical and health ETF highly sought after by the fund Last week, the average daily turnover rate of the fund was maintained at more than 5% Analysts pointed out that in addition to the market stimulus of the pharmaceutical sector, as the only cross market ETF of the pharmaceutical industry in the current A-share market, the outstanding advantages of the product also make it stand out The data shows that the coverage of China Securities pharmaceutical index to the current market value of the industry is as high as 77% Because the pharmaceutical stocks in Shanghai and Shenzhen are quite large, the cross market industry ETF can better represent the overall performance of the pharmaceutical sector At the same time, huitianfu also has rich ETF management experience As of September 27, the daily tracking deviation degree of huitianfu Zhongzheng medical and health ETF has been kept within 0.05% since it was listed, and the annual tracking error is only 0.38% Looking forward to the future trend of the pharmaceutical sector, there are several securities companies that have shown a good view of the pharmaceutical sector in the near future CSCI believes that with the development of bidding for basic drugs in various provinces at the end of October, the announcement of the third quarter report, the growth rate and valuation of individual pharmaceutical stocks will intensify differentiation, and the enthusiasm for investment in the pharmaceutical sector will rise again Cheng Dinghua, chief strategist at Anxin securities, said the weak market TCM sector would be favored again Analysts pointed out that the professional knowledge of the pharmaceutical industry is complex and the investment threshold is high For investors who are uncertain about individual stocks, huitianfu Zhongzheng medical and health ETF is a very good choice.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.